A procedure called EVT is creating radically better outcomes for patients, but only when it’s performed quickly enough — and that requires the transformation of an entire system of care.
Draft recommendations by the agency describe dry eyes, visual disturbances and other side effects of the procedure. Surgeons say the benefits are being ignored.
The tech multibillionaire said his company, Neuralink, was seeking government approval to test his device in people, and predicted it could happen in six months. Others have been conducting similar tests for years, but no device has been marketed commercially.